AIRS Medical Showcases Clinical Achievements in MRI Enhancement Solutions

(Seoul, South Korea) is showcasing its clinical achievements in MRI enhancement solutions at RSNA 2023. AIRS Medical is attending RSNA 2023 as an AI showcase sponsor, showcasing clinical achievements with two AI Theater presentations and two accepted abstracts.

AIRS Medical has achieved remarkable growth in the global market. The company obtained MDSAP (Medical Device Single Audit Program) certification, followed by three ISO certifications related to information security in September. In addition, AIRS Medical gained approval from Japan's Pharmaceuticals and Medical Devices Agency (PMDA) in October. These achievements have accelerated its global expansion, including in the Japanese market. AIRS Medical attributes its exceptional growth to its aggressive global expansion. By targeting the global market since the beginning of product development, the company has managed to obtain US FDA 510(k) clearance within just three months of launch. Subsequently, the company has gained approvals in several countries such as Asia-Pacific, Brazil, and the UAE. AIRS Medical has achieved MDSAP (Medical Device Single Audit Program encompassing five different countries including Japan.) certification in August. It also achieved another milestone by becoming the first company in the medical AI industry to obtain all three international standard information security certifications (ISO/IEC 27001, 27017, 27018).

AIRS Medical is showcasing SwiftMR, an AI-powered MRI enhancement solution, at RSNA 2023, the largest radiological conference in North America. SwiftMR is an AI-powered MRI reconstruction solution that improves the quality of MRI images by leveraging fine-tuned deep learning technology. It is capable of cutting MRI scan times by up to 50% while improving image quality. Since being launched in 2021, SwiftMR has been installed in over 250 institutions across the world, including the United States. It recently achieved over 900,000+ processed exams in less than a year as compared to just 300,000+ exams processed until November 2022. This huge threefold increase indicates SwiftMR’s effectiveness across the world. At RSNA 2023, the company is also presenting two AI Theater Presentations and two research abstracts, showcasing the domestic and international clinical research outcomes and success cases of SwiftMR.

"We are delighted to present clinical research collaboration outcomes and success stories of SwiftMR which supports our technological excellence at the RSNA. Our team's grand aim is to make SwiftMR a universal standard in all MRI scanners," said Kevin Yang, Head of AIRS Medical's U.S. branch and Clinical Research team.

Related Links:
AIRS Medical, Inc.